The global oncology-based in-vivo CRO market is worth US$ 1.1 Billion as of now and is expected to reach US$ 2.9 Billion by the year 2033 at a notable CAGR of 10.9% between 2023 and 2033. The WHO states that as of the year 2020, 19.3 Million novel cases of cancer were reported along with …
Author Archives: Editor AM
Global Chronic Refractory Cough Treatment Market is set to achieve a US$ 17.1 Billion valuation by 2033, fueled by a 6.39% CAGR | FMI
The Chronic Refractory Cough Treatment Market refers to the pharmaceutical and healthcare sector that focuses on providing treatments for chronic refractory cough (CRC). Chronic refractory cough is a persistent cough that does not respond to standard cough treatments and lasts for more than eight weeks. It can significantly impact a person’s quality of life and …
Global Diamond-Blackfan Anemia (DBAAASE) Syndrome Therapeutics Market is projected to experience a 4.2% CAGR increase between 2023 and 2033 | FMI
At a compound annual growth rate (CAGR) of 4.2% from 2023 to 2033, the Diamond-Blackfan Anemia (DBAAASE) Syndrome Therapeutics Market is expected to surpass an amazing US$ 4.8 billion in 2023. By 2033, the market for therapeutics for Diamond-Blackfan Anaemia (DBAAASE) Syndrome is anticipated to be worth US$ 7.29 billion. Due to the fact that …
Reusable Laparoscopic Instruments Market Poised to Reach US$ 6.3 Billion by 2033-FMI Study
The reusable laparoscopic instruments market is projected to be valued US$ 3.8 billion in 2023. It is anticipated that the market will grow at a 5.1% CAGR to reach US$ 6.3 billion by 2033. The market for reusable laparoscopic instruments is the area of the medical device industry that deals with the production, use, and distribution of …
Global Dengue Fever Treatment Market, affected by Climate Change and Increased Travel, is estimated to hit US$ 5435.25 Million by 2033, as per FMI analysis
The global dengue fever treatment market is expected to grow from US$ 877.82 million in 2023 to US$ 5435.25 million by 2033, at a CAGR of 20%. Dengue fever is a mosquito-borne viral infection that causes a flu-like illness. It is one of the most common mosquito-borne diseases in the world, and it is estimated …
Robot-Assisted Surgical Microscope Market Targets US$ 858.0 Million by 2033-FMI Study
The global market for Robot-Assisted Surgical Microscopes is on the brink of a profound transformation, with projections indicating a remarkable surge from US$ 410.6 million in 2023 to over US$ 858.0 million by 2033, at an impressive CAGR of 7.6% during this decade-long period. Robotics-assisted surgical microscopes represent a burgeoning sector within the wider medical device industry. …
Global Anorectal Malformation Treatment Market is estimated to undergo a 7.4% CAGR by 2033, as per FMI’s report
The global anorectal malformation treatment market is expected to surpass an impressive valuation of US$ 794.91 million in 2023 and is projected to exhibit a CAGR of 7.4% from 2023 to 2033, reaching US$ 1,475.19 million. The market is driven by a number of factors, including the rising prevalence of ARM, increasing awareness of the …
Global Bartonellosis Therapeutics Market is poised to hit a staggering US$ 3.72 Billion by 2033, driven by ground breaking treatments | FMI
The global bartonellosis therapeutics market size is anticipated to achieve an amazing valuation of US$ 1.2 Billion in 2023 and will reach US$ 3.72 billion by 2033, rising at a CAGR of 12% from 2023 to 2033. Future Market Insights (FMI) claims that. Bartonellosis is becoming more common, people are becoming more aware of it, …
Robotic Assisted Endovascular Systems Market Gears Up for a Valuation of US$ 214.7 Million by 2033-FMI Study
The global Robotic Assisted Endovascular Systems Market is poised for significant growth, with a projected market size of US$ 94.0 million in 2023 and an anticipated CAGR of 8.6% throughout the forecast period, propelling it to a valuation of US$ 214.7 million by 2033. The Robotic Assisted Endovascular Systems Market involves the application of cutting-edge robotic technology …
Global Abetalipoproteinemia Management Market is expected to reach US$ 341 Million by 2033, as per FMI’s report
The Abetalipoproteinemia Management Market is anticipated to expand from its current estimated value of US$ 147 million in 2023 to US$ 341 million by 2033, at a CAGR of 8.78%. The growing popularity of imaging tests like hepatic scans or ultrasonography to evaluate changes in fatty liver, as well as magnetic resonance imaging (MRI) of …